Louisiana State Employees Retirement System Invests $19.09 Million in Intuitive Surgical, Inc. $ISRG

Louisiana State Employees Retirement System acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the first quarter, HoldingsChannel.com reports. The institutional investor acquired 41,400 shares of the medical equipment provider’s stock, valued at approximately $19,085,000.

A number of other large investors have also recently bought and sold shares of the company. Fiduciary Alliance LLC grew its stake in shares of Intuitive Surgical by 39.4% during the 1st quarter. Fiduciary Alliance LLC now owns 1,218 shares of the medical equipment provider’s stock worth $570,000 after acquiring an additional 344 shares in the last quarter. Kestra Private Wealth Services LLC boosted its holdings in Intuitive Surgical by 1.1% during the first quarter. Kestra Private Wealth Services LLC now owns 51,002 shares of the medical equipment provider’s stock worth $23,511,000 after purchasing an additional 563 shares during the last quarter. Norway Savings Bank grew its position in Intuitive Surgical by 3.9% in the first quarter. Norway Savings Bank now owns 3,175 shares of the medical equipment provider’s stock valued at $1,464,000 after purchasing an additional 119 shares in the last quarter. Leeward Financial Partners LLC bought a new position in Intuitive Surgical in the first quarter valued at $1,525,000. Finally, Arta Finance Wealth Management LLC increased its stake in Intuitive Surgical by 11.0% in the 1st quarter. Arta Finance Wealth Management LLC now owns 2,236 shares of the medical equipment provider’s stock valued at $1,031,000 after buying an additional 221 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares of the company’s stock, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $473.46, for a total transaction of $236,730.00. Following the completion of the transaction, the director owned 239 shares in the company, valued at approximately $113,156.94. This trade represents a 67.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 7,169 shares of company stock worth $3,059,135. 0.60% of the stock is owned by company insiders.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Goldman Sachs and other industry analysts defended Intuitive Surgical’s core business, saying concerns over new rules on instrument reuse are unlikely to materially disrupt the company’s revenue model. Intuitive Surgical (ISRG) Faces Reuse Questions As Goldman Sachs Backs Fundamentals
• Positive Sentiment: Coverage comparing ISRG with Zimmer Biomet said Intuitive Surgical stands out on stronger revenue growth, rising procedure demand, and expanding AI-driven innovation, which supports a better upside case in 2026. ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
• Positive Sentiment: Intuitive Surgical received acknowledgement for its da Vinci Single Port robotic platform, reinforcing the company’s leadership in robotic surgery technology. Intuitive Surgical (ISRG) Garners Acknowledgement for Da Vinci Single Port Robotic Platform
• Neutral Sentiment: Short-interest data showed essentially no short interest in ISRG, so there is little evidence of bearish positioning from that metric alone.
• Negative Sentiment: Deutsche Bank reiterated a Sell rating and cut its price target to $366 from $440, adding to the analyst pressure weighing on shares. Deutsche Bank Maintains a Sell Rating on Intuitive Surgical (ISRG), Here’s Why
• Negative Sentiment: Broader commentary noted ISRG has been one of the market’s most punished large-cap healthcare names this year, reflecting investor concern despite ongoing revenue growth. Goldman Sachs Intuitive Surgical call goes against the grain

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $399.69 on Friday. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88. The stock has a market cap of $141.55 billion, a price-to-earnings ratio of 48.45, a PEG ratio of 3.27 and a beta of 1.46. The firm’s 50-day moving average is $433.94 and its 200-day moving average is $485.17.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter last year, the company posted $1.81 earnings per share. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ISRG. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. TD Cowen dropped their target price on Intuitive Surgical from $660.00 to $585.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Mizuho set a $525.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Deutsche Bank Aktiengesellschaft decreased their price target on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a research note on Tuesday, June 2nd. Finally, Jefferies Financial Group dropped their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research note on Wednesday, April 22nd. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $573.42.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.